Several pathways, such as the interferon (IFN)‐I pathway199 or TGF‐β signaling pathway,200 could act upstream of cancer‐derived exosomal checkpoint receptor ligands to trigger their secretion or induce the expression in the exosome, leading to a high tumor burden. Here, TGFB1 is linked to cancer.